Home MarketFortis Healthcare Ltd.

Fortis Healthcare Ltd. Stock Info: As on 2018-02-20 12:49:59

Nse

151.90

5.50(3.76%)
Change%
52 Week Range
107.10
6.00
228.95
3.00
Open150.50
Day's Range131.76 - 161.04
Value Traded (in ₹ Cr.) 986.18

Bse

149.60

3.25(2.22%)
Change %
52 Week Range
106.65
6.00
230.90
3.00
Open150.00
Day's Range131.72 - 160.99
Value Traded (in ₹ Cr.) 186.32

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 178,577,016.00 34.43%
Mutual Funds/UTI 48,435,062.00 9.34%
FII 157,515,880.00 30.37%
Employee 0.00 0.00%
Public 76,816,742.00 14.81%
Government 0.00 0.00%
Others 54,269,389.00 10.46%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 13.29
Basic EPS (Rs.) -1.59
Cash EPS -1.04
BVPerShare Excl 77.91
Operating Revenue 13.21
PBDITPerShare 0.63
Dividend 0.00
NPPerShare -1.59
Current Ratio 1.85
Quick Ratio 1.84
PriceToBV 2.25
Earnings -0.01
PBDIT Margin 4.80
PBT Margin -12.01
NP Margin -12.01
Return On Assets -1.49
Retention Ratios 0.00
Parameter Mar-16 (₹ Cr.) Yoy%change
Total Income 758.83
Total Expenses 817.00
EBITDA 29.39
PBT -73.51
PAT -73.51
Net Income -73.51
More
Parameter Mar-16 (₹ Cr.) 6M % change
Total Income 376.34
Total Expenses 367.99
EBITDA -5.60
PBT -30.78
PAT -30.78
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-16 (₹ Cr.) Yoy%change
Total share capital 463.13
Net worth 3,608.27
Investments 2,635.50
Total Liability 4,909.37
Total debt 1,044.54
Net block 349.23
Total Assets 4,909.37
Parameter Mar-16 (₹ Cr.) 6M % change
Total share capital 463.13
Net worth 3,608.27
Investments 2,635.50
Total Liability 4,909.37
Total debt 1,044.54
Net block 349.23
Total Assets 4,909.37
Company Curr Price Prev. Close Change% W's Low/High

Apollo Hospitals Enterprise Ltd.

1214.5 1186.2 2.39
11221244.2

Dr. Lal Pathlabs Ltd.

903.45 901.5 0.22
890924.95

Healthcare Global Enterprises Ltd.

321.5 323.6 -0.65
315.4336.4

Indraprastha Medical Corporation Ltd.

54.25 54.25 0
53.9559.3

Kovai Medical Center and Hospital Ltd.

641.65 624.85 2.68
629.9649.9

Lotus Eye Hospital and Institute Ltd.

31.05 31.05 0
30.933.65

Marico Kaya Enterprises Ltd.

1547.05 1582.55 -2.24
1535.051589
Company Curr Price Prev. Close Change% W's Low/High

ADS Diagnostic Ltd.

11.34 10.8 0
11.3411.34

Apollo Hospitals Enterprise Ltd.

1210 1187.05 1.93
11211245

Birla Pacific Medspa Ltd.

0.28 0.27 0
0.270.28

CDR Health Care Ltd.

7.58 2.6 0
7.227.58

Chennai Meenakshi Multispeciality Hospital Ltd.

28.45 29 -1.9
28.4531.1

Dhanvantri Jeevan Rekha Ltd.

33.3 34.4 -3.2
32.536.4

Dolphin Medical Services Ltd.

1.31 1.34 -2.24
1.281.35
More
Parameter Mar-16(in ₹ Cr.)
Cash from operating activities -693.61
Cash from investing activities 379.12
Cash from financing activities 317.58
Net change in cash 3.09

Stock Held By Mutual Fund Schemes

Scheme Holding (%)
ICICI Prudential MidCap Fund 3.64%
Aditya Birla Sun Life Balanced 95 Fund 0.37%
Aditya Birla Sun Life Enhanced Arbitrage Fund 1.07%
ICICI Prudential Equity - Arbitrage Fund 0.45%
Kotak Equity Arbitrage Fund - Regular Plan 0.39%
HDFC Arbitrage Fund - Regular Plan 0.84%

Sebi revokes curbs on Sanco Industries

Markets regulator Sebi has lifted the curbs imposed on Sanco Industries, which was among the suspected shell companies, after finding no prima facie evidence of misrepresentation of financials by the company. ...I do not find any prima facie evidence nor suspicion of misrepresentation of financials/ business by the company (Sanco Industries), misuse of books of accounts/ funds of the company or violation of LODR (Listing Obligations and Disclosure Requirements) Regulations, Sebi Whole Time Member Madhabi Puri Buch said in an order dated February 15. Buch also said that she is of the considered view that the actions envisaged in Sebi's letter dated August 7, 2017 against Sanco Industries are liable to be revoked. Sanco Industries was among the firms against whom the Securities and Exchange Board of India (Sebi) initiated action on August 7 by ordering trading restrictions, following receipt of a list of 331 'suspected shell companies' from the government. The ordered trade restrictions - allowing trade only once a month and that too for only buy transactions with a 200 per cent security deposit - were revoked in some cases a few days later following appeals filed by them with the Securities Appellate Tribunal, but Sebi was asked to continue with its probe and pass its orders expeditiously.

20-02-2018 10:04

Promoter buys stake worth Rs 111 cr in KEC Intl

KEC International's promoter Instant Holdings today bought over 1 per cent stake in the infrastructure major for Rs 111 crore through an open market transaction. According to the block deal data available with the BSE, the promoter purchased 28.05 lakh shares, amounting to 1.09 per cent stake in the firm. The shares were acquired at an average price of Rs 395.95, valuing the transaction at Rs 111.07 crore, the data showed. At the end of the December 2017 quarter, Instant Holdings held 1.80 crore shares, or 7.01 per cent, in KEC International. The shares were sold by Stellar Energy Trust. In a separate block deal, Instant Holdings disposed of 14.81 per cent stake in the drug firm RPG Life Sciences for Rs 110.94 crore. The data showed that Instant Holdings, a promoter of RPG Life Sciences, offloaded 24.50 lakh shares, or 14.81 per cent, in the drug firm. The shares were sold at a price of Rs 452.85 apiece, translating into a transaction worth Rs 110.94 crore. Instant Holdings controlled 16.53 per cent stake in RPG Life Sciences at the end of December 2017 quarter. The shares were purchased by Nucleus Life Trust. Meanwhile, shares of the company were trading at Rs 384.45 apiece, up 2.11 per cent from the previous close at 10:11 hours on BSE.

20-02-2018 10:04

Prime Focus’ arm bags award for Best Special Visual Effects

Prime Focus has said that its arm Double Negative (DNEG) has been honoured at the BAFTA awards 2018 for its work on ‘Blade Runner 2049’. The film picked up the award for ‘ Best Special Visual Effects ’ at the star - studded ceremony last night. This is the third award that DNEG has won in less than a week , having picked up two Visual Effects Society awards last Tuesday for its work on Denis Villeneuve’s ‘Blade Runner 2049’ and Christopher Nolan’s ‘Dunkirk’. DNEG was the lead Visual Effects house for both films , and is also nominated in the ‘ Best Visual Effects’ category for its work on ‘Blade Runner 2049’ at the 90th Academy Awards on March 4th 2018 in Los Angeles. Led by VFX Supervisor Paul Lambert, DNEG’s Blade Runner team delivered most of the Los Angeles 2049 cityscapes, the Joi hologram effects and the seawall chase at the end of the movie. Meanwhile, shares of the company closed at Rs 101.15 apiece, down 1.27 per cent from the previous close at 10:03 hrs on BSE.

20-02-2018 10:03

IndiGrid completes acquisition of three assets

IndiGrid has said that it has completed the acquisition of three assets - RAPP Transmission Company Limited, Purulia and Kharagpur Transmission Company Limited and Maheshwaram Transmission Limited from its Sponsor- Sterlite Power Grid Ventures Limited . It has simultaneously signed definitive agreements with Techno Electric & Engineering Company Limited to invest in Patran Transmission Company Limited (“PTCL”). The purchase consideration for MRP is INR 14.10 billion and for PTCL is INR 2.32 billion. Both these acquisitions are highly accretive and will increase portfolio IRR to 11% at current price. They will enable IndiGrid to deliver a DPU of at least INR 12 for the next five years . Commenting on the developments, Pratik Agarwal, Chief Executive Officer, IndiGrid , said, “ In line with its vision of reaching an AUM of INR 300 billion, IndiGrid has successfully completed the first set of the acquisition s. Further, we have demonstrated our ability to pursue third party assets by signing definitive agreement s with Techno Electric . The fundamentals of the power transmission sector in India remain robust and IndiGrid will continue to acquire assets from both the Sponsor and third parties to further increase portfolio IRR ” .

20-02-2018 10:00

NTPC pays interim dividend of Rs 2,251 cr to shareholders

State-run power giant NTPC today said it has paid interim dividend of Rs 2,251 crore for 2017-18. For the financial year 2017-18, NTPC Ltd has paid an interim dividend of Rs 2,251.01 crore,being 27.30 per cent of the paid-up equity share capital of the company, an NTPC Ltd statement said. According to the statement, the real-time gross settlement advice for the transfer of Rs 1,401.81 crore, to the Government of India, being its share in the interim dividend, was presented by NTPC CMD Gurdeep Singh to R K Singh, Minister of State for Power and New and Renewable Energy.This is the 25th consecutive year that NTPC has paid dividend, it added. Meanwhile, shares of the company were trading at Rs 163.45 apiece, up 0.28 per cent from the previous close at 10:06 hours on BSE.

20-02-2018 09:57

Fortis Healthcare - Fortis Healthcare Ltd reply to clarification sought by the exchange

The Exchange had sought clarification from Fortis Healthcare Ltd with respect to news appearing in www.timesofindia.com - February 19, 2018 titled Fortis, Religare face serious fraud probe; Sebi orders inquiry

Fortis Healthcare Ltd response is enclosed.

19-Feb-2018 06:16 PM

Fortis Healthcare - News Clarification

The Exchange had sought clarification from the Company with respect to news item captioned SFIO probe against Fortis and Religare. The response from the Company is enclosed

19-Feb-2018 06:07 PM

Fortis Healthcare - Clarification sought from Fortis Healthcare Ltd

The Exchange has sought clarification from Fortis Healthcare Ltd with respect to news article appearing on www.timesofindia.com - February 19, 2018 titled Fortis, Religare face serious fraud probe; Sebi orders inquiry.

The reply is awaited.

19-Feb-2018 05:21 PM

Fortis Healthcare - News Clarification

The Exchange has sought clarification from the Company with respect to news item captioned SFIO probe against Fortis and Religare In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.

19-Feb-2018 05:08 PM

Malvinder Singh restrained from selling properties in bank loan default case

The Delhi Debts Recovery Tribunal (DRT) has restrained former CEO of Ranbaxy Laboratories and the co-owner of Fortis Healthcare, Malvinder Mohan Singh, from selling a posh property in Lutyen's Delhi and some other assets in a bank loan default case, reported PTI. A bench headed by presiding officer GVK Raju passed the interim direction on an application by Yes Bank seeking recovery of Rs 569.64 crore loan given to Oscar Investment Ltd. for which Singh was a guarantor. In the facts and circumstances of the case, defendants, their men or agents are restrained from alienating or creating any sort of encumbrance in respect of the immovable property, i.e., 1, Rajesh Pilot Marg, until further orders, the court said, while also restraining him from selling some of his other assets including properties. The bank had filed an application through its law officer, advocate Navin Trivedi, claiming that the defaulters, with an intention to defeat its rights, are trying to alienate the movable and immovable property and if they are permitted to do so, the bank would suffer irreparable loss.

19-Feb-2018 10:32 AM

Fortis Healthcare - Fortis Healthcare Ltd reply to clarification sought by the exchange

The Exchange had sought clarification from Fortis Healthcare Ltd with respect to news appearing in www.timesofindia.com - February 19, 2018 titled Fortis, Religare face serious fraud probe; Sebi orders inquiry

Fortis Healthcare Ltd response is enclosed.

19-Feb-2018 06:16 PM

Fortis Healthcare - Clarification sought from Fortis Healthcare Ltd

The Exchange has sought clarification from Fortis Healthcare Ltd with respect to news article appearing on www.timesofindia.com - February 19, 2018 titled Fortis, Religare face serious fraud probe; Sebi orders inquiry.

The reply is awaited.

19-Feb-2018 05:21 PM

Fortis Healthcare - Announcement under Regulation 30 (LODR)-Updates

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received a communication from Securities and Exchange Board of India (SEBI) vide Ref. No. SEBI/HO/IVD/ID2/PS/CMR/FHL/5288/1/2018 dated February 16, 2018, confirming that an investigation has been instituted by SEBI in the matter of FORTIS HEALTHCARE LIMITED. Vide aforesaid letter, SEBI has asked to furnish information and documents as mentioned therein by February 26, 2018. The Company is in process of collating the said information and will be sharing the same with SEBI in due course. The financial implication/ compensation/penalty and quantum of claims has not been referred in the aforesaid letter and hence cannot be ascertained.


We will keep the stock exchanges informed about any further updates in this regard

17-Feb-2018 04:35 PM

Corporate Details

About Management

The registered office of the Company was initially situated at 25, Nehru Place, New Delhi 110 019, India. Pursuant to a Board resolution dated September 16, 2003 the registered office was shifted to B- 9, Maharani Bagh, New Delhi 110 065, India. Subsequently, pursuant to Board resolution dated February 10, 2006 the registered office of the Company was shifted to Piccadily House, 275- 276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi 110 065, India, which is the current Registered Office. Scheme of merger/amalgamation between Fortis Medical Centre Holdings Limited and the Company dated October 7, 2005: The High Court of Delhi, through its order dated October 7, 2005 in respect of the company petition (C.P. No: 240/2005 and 241/2005) approved the scheme of amalgamation/merger between the Company and Fortis Medical Centre Holdings Limited ("FMCHL"), and which at the time of amalgamation was our board controlled subsidiary, with effect from April 1, 2004 ("Scheme"). Salient features of the Scheme: The principal terms of the Scheme, as sanctioned by the High Court of Delhi, are set forth below: The entire undertaking and business, all properties, tangible and intangible assets including trademarks, patents, design, copyrights, investments, approvals, licenses, tax benefits, pending projects, debts, liabilities and obligations, including income tax liabilities accrued or to accrue in FMCHL was transferred to the Company with effect from April 1, 2004. Pursuant to the Scheme, Fortis Hospital, Amritsar was transferred to the Company. However, the transfer of the aforesaid was subject to the existing charges or hypothecation in respect of the assets of FMCHL. All the staff, workmen and employees of FMCHL in employment on the date immediately preceding December 23, 2005 (i.e., the date on which a certified copy of the order of the High Court of Delhi was filed with the RoC) became the employees of the Company without any break or discontinuity in service and on conditions not less favourable than those subsisting at FMCHL. In consideration of the transfer and vesting of the undertaking and the assets and liabilities of FMCHL and in consideration of the mutual covenants agreed to in the Scheme, the Company agreed to allot the Equity Shares to the existing shareholders of FMCHL, in the ratio of 1:4 (i.e., one Equity Share in exchange of every four equity shares of FMCHL of Rs. 10 each). In compliance with the Scheme, the Company allotted 520,000 Equity Shares to the shareholders of erstwhile FMCHL on February 10, 2006. Major Events: Year Event June 2001 Commissioning of Fortis Hospital, Mohali. August 2003 Inauguration and commissioning of Fortis Hospital, Amritsar. October 2003 Executed an agreement with Seth Jessa Ram and Bros Charitable Hospital Trust for the operation and management of Jessa Ram Hospital, New Delhi. August 200 Commissioning of Fortis Hospital, Noida. September 2005 Acquired 90% of the equity share capital of Escorts Heart Institute and Research Centre Limited resulting in the acquisition of EHCL, EHSSIL, EHSSHL and EHRCL. October 2005 Signed an agreement with Jeewan Mala Hospital Private Limited for the operation and maintenance of Jeewan Mala Hospital, New Delhi. January 2006 Signed an agreement with Sunrise Medicare Private Limited for the operation and management of Fortis La Femme, New Delhi, and acquisition of 5% equity interest in Sunrise Medicare Private Limited, with an option to acquire additional equity shares. January 2006 Signed an agreement with Khalil Public Welfare Trust for the operation and maintenance of Khyber Medical Institute, Srinagar. March 2006 Acquired 99.99% of the paid up equity share capital of International Hospital Limited resulting in the acquisition of Fortis Hospital, Noida. March 2006 Acquired 100.00% of the paid up equity share capital of Oscar Bio-Tech Private Limited. 2004 -Fortis inks deal with Jessa Ram Hospital to takeover the management of the hospital 2005 -Fortis Hospital rolls out Golden Age Club -Fortis buys Escorts Heart -Fortis Healthcare signs $33.33m pre-IPO deals The Company was incorporated on February 28, 1996 as Rancare Limited under the Companies Act. Subsequently on June 20, 1996 our name was changed to our present name-Fortis Healthcare Limited. The Company received the certificate of commencement of business on July 1, 1996. 2006 -Fortis Healthcare to buy majority stake in Trehan`s Medicity -Fortis Healthcare signs $33.33m pre-IPO deals 2007 -Fortis HealthWorld has joined hands with US hearing aid maker Starkey for its Audible range and is looking to soon offer dental services at its Health stores too. -Colgate-Palmolive India, the market leader in toothpaste in India, declared the acquisition of three domestic companies in south India recently. The company purchased 75 per cent equity in Advanced Oral Care Products (Goa), Professional Oral Care Products (Goa) and SS Oral Hygiene Products (Hyderabad). -Fortis Healthcare acquires Hiranandani Hospital 2008 -Fortis Healthcare Ltd has informed that the Board of Directors of the Company at its meeting held on January 23, 2008, inter alia, has approved change in registered office of the Company from "Piccadily House, 275-276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi - 110065" to "Escorts Health Institute And Research Centre, Okhla Road, New Delhi - 110025". 2009 -Fortis completes Wockhardt Hospital Acquisition -Fortis signs $15 mn outsourcing deal with HCL -Fortis Healthcare Ltd Issues Rights in the Ratio of 2:5 2010 - 25% stake in Parkway holdings, Asia's largest private healthcare provider. - "Fortis Healthcare infuses USD 100 Million". - Fortis increases stake in Parkway. - Government of Singapore Investment Corp (GIC) to join hands with Fortis at strategic level. - Fortis Healthcare has entered into a pact with two hospitals in Dubai and Tanzania to set up specialised medical facilities. - Company has announced its foray into Speciality Medical Centres focused on the management of diabetes, metabolic diseases and endocrinology. 2011 - A Memorandum of Understanding has been signed by Fortis Healthcare Ltd with the University of Utah to develop courses for Emergency Medical Technicians. - Through its wholly owned subsidiary, has entered into an agreement with Cauvery Hospital Limited, Mysore, wherein Fortis will set up, operate and manage a Cardiac Centre in the hospital. - The name of Fortis Healthcare Limited shall be changed to Fortis Healthcare (India) Limited w.e.f. April 11, 2011. - "Fortis Healthcare ties up with TotipotentRX to set up Stem Cell Therapy Centres". - Fortis Healthcare (India) Ltd has announced that it will buy 86 per cent stake in Super Religare Laboratories Ltd (SRL) . - Fortis Healt - Fortis announces new hospitals in Hyderabad and Agra. 2012 - "Fortis to get Rs. 3700 Mn Equity infusion in SRL through IFC and NYLIM Jacob Ballas India". - Fortis Healthcare raises around S$510 mn through Singapore IPO. -Company has changed its name from Fortis Healthcare (India) Ltd. to Fortis Healthcare Ltd. 2013 -"Fortis launches its Flagship Hospital, One of the First of its Kind in Asia Bridges the gap for expert talent, trans-disciplinary, quaternary care". -"Fortis to divest stake in Quality Healthcare to Bupa for US$ 355 million Intensifies Focus on Healthcare Delivery in India". 2014 -"Fortis launches state of the art, multi super-specialty hospital in Ludhiana". 2016 -Fortis Healthcare has fully acquired Religare Health Trust Trustee Manager for USD 14.9 million (about Rs 100 crore). -Fortis group gets CCI nod for internal reorganisation. -Fortis Healthcare First in India to Monitor and Publish Clinical Outcomes for Cardiology. -Fortis Healthcare launches National helpline for students and parents to help deal exam stress.

Registered Office

Fortis-Escorts Hospital: 2nd Floor, Coronation Hospital, Curzon Road,

,,,      ,

Registrar Details

Karvy Computershare Private Ltd.